Our Mission
Puma Biotechnology is a biopharmaceutical company dedicated to the acquisition, development, and commercialization of novel therapeutics for the treatment of cancer.
Clinical Trials
ALISCA®-Lung2 Active Sites - United States
Below is a list of study sites currently open to enrollment as of 26OCT2026 . Please note study site availability for enrollment is subject to change without notice. Please contact Puma at clinicaltrials@pumabiotechnology.com should you have any questions regarding open sites.>
Center Name
City
State
Phone